Form 8-K - Current report:
SEC Accession No. 0001193125-20-105808
Filing Date
2020-04-14
Accepted
2020-04-14 07:31:04
Documents
4
Period of Report
2020-04-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d891047d8k.htm 8-K 39105
2 EX-99.1 d891047dex991.htm EX-99.1 20433
3 GRAPHIC g891047kyowakirinlogo1.jpg GRAPHIC 8882
4 GRAPHIC g891047meilogo1.jpg GRAPHIC 5890
  Complete submission text file 0001193125-20-105808.txt   81535
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 20790062
SIC: 2834 Pharmaceutical Preparations